CellGeneticsPeer-reviewed journal article
Somatic evolution in non-neoplastic IBD-affected colon
Sigurgeir ÓlafssoniD, Rebecca E. McIntyreiD, Tim H. H. CoorensiD, Timothy M. ButleriD, Hyunchul JungiD, Philip S. RobinsoniD, Henry Lee-SixiD, Mathijs Arnoud SandersiD, Kenneth Arestang, Claire Dawson, Monika Tripathi, Konstantina Strongili, Yvette E. Hooks, Michael R. StrattoniD, Miles ParkesiD, Iñigo MartincorenaiD, Tim RaineiD, Peter J. CampbelliD, Carl A. AndersoniD
Abstract
Summary paragraphInflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. Here, we whole-genome sequenced 447 colonic crypts from 46 IBD patients, and compared these to 412 crypts from 41 non-IBD controls. The average mutation rate of affected colonic epithelial cells is 2.4-fold that of healthy colon and this increase is mostly driven by acceleration of mutational processes ubiquitously observed in normal colon. In contrast to the normal colon, where clonal expansions outside the confines of the crypt are rare, we observed widespread millimeter-scale clonal expansions. We discovered non-synonymous mutations in ARID1A, FBXW7, PIGR and ZC3H12A, and genes in the interleukin 17 and Toll-like receptor pathways, under positive selection in IBD. These results suggest distinct selection mechanisms in the colitis-affected colon and that somatic mutations potentially play a causal role in IBD pathogenesis.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- approach: statistical model
- Citations
- 208
- FWCI
- 17.42
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The landscape of somatic mutation in normal colorectal epithelial cells
H. Lee-Six, P. Ellis, … M. R. Stratton·bioRxiv·Sep 13, 2018
- Susceptibility to inflammatory bowel diseases promotes invasive carcinomas in a murine model of ATF6-driven colon cancer
Janine Kövilein, Adam Sorbie, … Dirk Haller·Journal of Crohn s and ColitisPeer-reviewed·Jul 1, 2025
- Identifying novel high-impact rare disease-causing mutations, genes and pathways in exomes of Ashkenazi Jewish inflammatory bowel disease patients
Yiming Wu, Kyle Gettler, … Yuval Itan·medRxiv·Jul 1, 2020
- Pervasive bacterial and prophage hybridization during chronic gut inflammation
Marta Lourenço, Elsa Seixas, … Isabel Gordo·bioRxiv·May 27, 2026
- Poor prognosis in IBD-complicated colon cancer through gut dysbiosis-related immune response failure
Iradj Sobhani, Nilmara de Oliveira Alves, … Denis Mestivier·bioRxiv·Mar 25, 2025
- Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseases
Mitchell W. Pesesky, Ramit Bharanikumar, … Matthieu Allez·Journal of Crohn s and ColitisPeer-reviewed·Mar 13, 2025